Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CETX just a few more cents to get filled... I'll say now that I'm almost expecting this one to move down to the upper 3 range again, so I don't even know if I want it filled anymore, ha
CETX Got my buy order set at 4.65! Although I am a little concerned it goes back to the upper 3/lower 4 range like it was for many months last year, so I wouldn't mind it popping back up to the 20 day either.
sounds like a plan, thanks
CETX Curious if this does recover, what would be your target? 7? Or do you think this will bounce back to 8?
CETX Nice! I started a position at 5.10. And lol, green today?! I'd love to see that and would be very impressed at your prediction as I don't think it has any shot! I'll be prepared to buy more tomorrow at 4.60. Seems like a pretty solid bottom at 4 from last year.
GORO Back to 6s! It's not often a stock does what I think it will, maybe I am learning? Ha! Tempted to sell now, but my plan was to wait for the eventual big market down day(s). Am also looking into VGZ and GSS.
CETX Another one I've been watching after reading your posts here. Seems like 5 is a decent starting buy point with a bottom in the low 4s?
GORO Bought more this morning on the drop. Look for a bounce back to 6, maybe this week.
GORO Bought the other day. What's your target?
Also, been following this board for about a week now. Some pretty good suggestions, much appreciative!
Agreed. I don't plan on selling it all but my money is better off somewhere else, even with the loss I'll take. Maybe one day they'll do something great, but this just isn't a smart bet right now.
Highest 5 day volume in over a year. I'm going to try to take advantage of this and start to sell this one off. I would have no problem waiting longer but they show no signs of getting up to date on financials and no longer provide any updates. And because of this, nobody posts here anymore because there's nothing to discuss. Disappointing, but they can't all be winners I suppose.
Similar pattern everyday this week. A small buy bids it up to 8, then a large sell brings it back to 4. While a different pattern, the slow selling has been occurring for the last 3-4 months. Just seems like a matter of time before this drops even lower.
It's nice to see but at this rate, they will continue falling further and further behind on their financials, so it's almost too little too late. However, I skimmed through it. Maybe they can get one more update or 10Q out before the end of the year, then I'd consider giving them more time before exiting.
With sell volume everyday and the pps dropping, it appears someone is exiting their position. Probably a smart idea. Maybe I should have done that instead of giving them more time!
Well, the week started off somewhat promising but ended as expected. I've given this one over 2 years now and from promised revenue that was never realized to not reporting, my patience is waning. I would be perfectly fine waiting if they kept up on quarterlies but I've been in companies that quit reporting before and it doesn't end well.
True, excited is not the right word. Basically it's just something to do to keep my interest while we wait for a possible buyout/merger. Maybe boredom is the right word? I absolutely expect the volume and pps to drop next week. Although when you look at the volume combined with ending pps, yesterday was top 10 highest for the last year.
It appears someone still believes they are with the highest volume today in 3 months. Hopefully something is up and the something is good.
This has quietly surpassed the most consecutive days with volume for this year. Doesn't mean much but it is nice to see some trades while we wait for a potential buyout or merger. Also appears that getting the 10Qs caught up is no longer on the to-do list, although maybe it never was.
I believe they got behind last summer due to clinical trials and are just getting caught back up this year. This is why they have released the last two 10Qs about every two months. I expect (hope) to see another one by mid-June.
In the end though, the financials here don't matter much when it comes to the pps. The only way the pps increases from here is through a buyout, merger or partnership. Until then, it's a waiting game and/or a test of patience for some, as we see the pps bounce off of all time lows.
Thought of this scam stock today for the first time in over a year. I see it's continued to be dead here. Glad I sold way back when and kept some of my money!
Deleted Repost.
Noticed news came out this morning. It would be nice to know who they sell their discovery tools to and at the very least, how much is being sold or maybe even an announcement of an order. So doesn't mean a whole lot overall but it is nice to see something from them about once a month.
GOLDEN, CO / ACCESSWIRE / May 3, 2016 / Vitro Diagnostics, Inc. (VODG), dba Vitro Biopharma, announced the launch of breast cancer CAFs (cancer-associated fibroblasts) that provide additional tools for drug discovery in the quest to eradicate cancer. CAFs reside within tumor tissue and serve various functions including suppression of immune responses to cancerous cells, support of tumor cell growth and enhancement of metastasis. Modern immunotherapy has evolved into CAR-T technology (chimeric antigen receptor T cells) whereby patient's immune cells are genetically engineered to migrate to, attach to and eliminate cancer cells. Several biotech firms are developing CAR-T cancer immunotherapeutic products including Juno Therapeutics, Kite Pharma and Ziopharm Oncology. Some early trials for treatment of leukemia show nearly complete remission using this therapy. However, CAFs present within solid tumors continue to block engineered T cells and require intervention to maximize immunotherapy to completely eradicate cancerous cells (PNAS 110: 20212, 2013).
Our CAF product line now includes several tumor-specific CAFs including lung, colorectal, pancreatic and we also provide our specialized cell culture medium, Vitro Plus IIIâ„¢, for the expansion and use of these cell lines in cell-based assays for cancer drug discovery. With the addition of breast CAFs we now provide a broader array of CAF offerings to advance the race for a cure for cancer. Immunotherapy is at the forefront of the fright to eliminate cancer through a targeted approach designed to selectively eradicate cancer tumor cells from the body: http://www.cancer.gov/about-cancer/treatment/research/car-t-cells.
Dr. Jim Musick, President & CEO of Vitro Biopharma said, "We are very pleased to announce the latest addition to our cancer research tools. Use of the immune system to selectively target and eliminate cancerous cells from the body was pioneered by Dr. Steven Rosenberg at the National Cancer Institute (NCI). The recent expansion to CAR-T technology adds enhanced specificity and potency to the process. Immunotherapy has the potential to provide significant advances to our abilities to treat cancer and may be a crucial tool in the eradication of cancer. Vitro Biopharma has a history of involvement in cancer research through a previous contract with NCI in the 1990's to supply a recombinant human tumor marker, CEA (carcinoembryonic antigen). More recently, our pancreatic primary fibroblast cell line and CAFs have been used extensively in cancer research. We now sell our cancer drug discovery tools to large biopharmaceutical companies and several other research labs throughout the world. We also plan to further expand our CAF product line in the future."
Assuming they continue to file every two months, they'll be caught up by the end of this year! Kind of sad this is good news but it's all we got right now.
If they are to continue on their own (let's hope not!) it seems the key thing here is getting their filings up to date. I doubt we see the >10c pps fluctuations again without that.
Instead of this PR, I wish they would put their time towards getting their late 10Qs filed or actually expanding their production by five-fold instead of just stating what they said they would complete last year. Hopefully this year is a better year for them growth wise, but I'm still thinking the best shot here is through a partnership or acquisition, which I am glad they mentioned.
No big story here. I first got in about 1.5 years ago when they were expecting 3-4x revenue growth and profitability, however that fell through and they quit reporting their 10Qs, although they just completed their one from April 2015. Now everyone seems to be stuck waiting around for a possible merger or acquisition (see Aug 31 8K), which the longer it takes the more people are exiting, similar to the action today. As it currently sits, not enough resources to apply the science/technology. Overall, it's had better days and I used to be excited about the possibility here, but it has gone to a complete "crap shoot" type stock for me. Who knows though, might still get acquired in the 20c range.
Wow, I am very surprised to see they filed the 10Q from last spring. At this point though I don't think it means much, even if they file the remaining late 10Qs.
As expected, back to bidding 6. Same pattern since the summer but even more telling was the convertible that was issued at 4. I might try to get more shares under 5, however there's some things occurring here where we've heard no explanation for from Musick. So a lot of unknowns, which could be viewed two ways:
Positive- These just can't be explained quite yet due to an acquisition/merger
Negative- Recently hired director leaving and convertible dilution.
I had assumed (perhaps wrongly?) that the convertible was associated the possible acquisition or merger. But looking back at the 8K in August, it states that restricted shares will be used for those legal fees, so now I'm not sure? Without the August 8K, this one would be taken very negatively, especially combined with the fact that they haven't reported since March.
A lot of interesting things happening with this company and let's hope they turn out for the good.
Well, that was a quick time in service for Jeff Liter. Back when he was appointed, it was thought of as a significant event that should have boded well for the future. I have to think that now he has resigned that it is also a significant event, meaning all signs point toward VODG being controlled by a different company or having access to more resources with the help of a different company within a few months? Any insight would be helpful.
Been a month since releasing their annual letter to shareholders, which was plenty of time to file their 10Qs, however I am convinced that they have no plans to. In the end, they don't need to and if they plan on being acquired or merging, there doesn't seem to be much point in filing on their own anymore. Hopefully they are working on good things behind closed doors.
That's definitely food for thought. On one hand, the private company would hopefully add to/increase revenue streams much easier with access to more resources to distribute product, and with increased revenue would hopefully come with positive earnings and ultimately get more eyes here/larger investors. On the other hand, with more shares comes more difficulty to achieve higher positive EPS (assuming that comes) and on the flip (and current) side, higher negative EPS. Not to mention owning much less of the company. Overall, it sounds positive, but still more risky than just a straight buyout.
First no volume day since Sept 23. Quite the streak this had going, especially for this stock that averages about 1 no trade day a week. Kind of a stalemate today with the bid about 7 and ask about 12. I think the bid will ultimately win but still hold out hope they file and the ask wins. It seemed like the perfect time after the shareholder update last week. We'll see.
Thanks for the info. Not so sure about a reverse merger, although I don't have any experience with them other than what I've read. Would the private company still have to purchase VODG for a higher pps?
I, too, am hoping for a move to the above 15 range. A year ago, there was a wall about 13-15 range as well, which it went through and held for several months and I believe would have held if it wasn't for the unexpected revenue drop. Hopefully we see revenue begin to increase in fiscal 2016 and the pps will be able to hold 15, but of course we need that increased corporate activity you talk about for that to happen.
Well, looks like I was wrong and finally got caught here. Still about breakeven for winning a few times and now losing. Can only play poor stocks for so long I guess before it's time to move on.
Oh and the volume today is also promising. I think a 300k day is very likely and hopefully even higher. Although again, if the volume drops, so will the pps.
The bid is promising, however this is the same area the pps was in after the 8-K filing. This needs to break through above 14-15 or else the pps will ultimately drop back to the 5 range. And who knows, it might drop back down there no matter what if they don't file the 10Qs.
That does sounds good and I honestly wish I could believe him, but it also sounded good last year. Fool me once... So based on the past, I can't believe much he says when discussing financials. Just another reason to get this company sold, so he can focus on the research and leave the financials to others.
Thinking about the filing issues more, the facts point towards this company never filing another 10Q. But rather, an acquiring company will handle all the loose financial ends. Unfortunately, because of all the loose ends, that drives the purchase price way down.
I suppose it's also very possible the pps is being taken down for a buyout to occur at a price below 10 cents.